Income statement, balance sheet and cash flow statement for the last 8 fiscal years, taken from the XBRL data ChargePoint Holdings, Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2020
FY2020
FY2022
FY2022
FY2023
FY2024
FY2025
FY2026
Revenue
145
146
241
468
507
417
411
Cost of revenue
126
114
187
382
477
316
286
Gross profit
18
32.9
53.5
85.9
30.1
101
126
Research and development
69.5
75
145
195
221
141
139
Selling and marketing
57
53
92.6
142
150
131
101
General and administrative
23.9
5.75
25.9
81.4
90.4
109
81.5
95.7
Operating expenses
150
154
319
428
480
354
336
Operating income
-132
-5.95
-121
-265
-342
-450
-253
-210
Interest expense
3.54
3.25
1.5
9.43
16.3
24.7
23.9
Interest income
3.25
0.32
0.1
5.53
9.6
8.35
4.49
Other non-operating income
-0.57
0.23
-2.78
-1.57
-1.01
-3.39
2.14
Pre-tax income
-134
-315
-197
-135
-347
-458
-273
-216
Income tax
0.22
0.2
0.2
-2.93
-2.17
-0.02
4.37
4.05
Net income
-134
-315
-197
-132
-345
-458
-277
-220
EBITDA
-125
-111
-249
-317
-421
-224
-183
EPS, basic
-301.63
-362.35
-20.18
-20.37
-24.37
-12.78
-9.41
EPS, diluted
-301.63
-362.35
-29.76
-20.37
-24.37
-12.78
-9.41
Shares, basic (weighted)
0.45
0.76
14.9
16.9
18.8
21.7
23.4
Shares, diluted (weighted)
0.45
0.76
15.1
16.9
18.8
21.7
23.4
Balance sheet
FY2020
FY2020
FY2022
FY2022
FY2023
FY2024
FY2025
FY2026
Cash and equivalents
72.8
0.11
145
315
264
327
225
142
Short-term investments
0
0
105
0
Receivables
35.1
75.9
165
124
95.9
86.1
Inventory
33.6
35.9
68.7
199
209
215
Other current assets
0.24
8.09
19.7
22.6
18.9
20.5
13
Total current assets
0.35
227
464
704
743
567
462
Property, plant and equipment
30
34.6
40
42.4
35.4
24.7
Lease right-of-use assets
21.8
25.5
22.2
15.4
14.7
11.5
Goodwill
1.22
218
214
214
208
228
Intangible assets
0
107
92.7
80.6
66.2
60.5
Other non-current assets
10.5
6.02
7.11
8.57
7.85
5.63
Total assets
317
290
856
1,080
1,103
898
792
Accounts payable
0.04
19.8
27.6
62.1
71.1
64.1
90.1
Accrued liabilities
4.13
18.4
31.9
46.1
51.4
37.2
46.2
Deferred revenue
40.9
77.1
88.8
100
105
119
Short-term debt
10.2
0
0
32.4
Total current liabilities
5.93
118
189
284
330
294
384
Long-term debt
24.7
0
295
284
297
228
Lease liabilities
22.5
25.4
21.8
17.4
15.3
10.7
Other non-current liabilities
0.97
7.1
1.03
1.76
8.37
3.98
Total liabilities
337
291
309
725
776
761
771
Total debt
34.9
0
295
284
297
261
Paid-in capital
296
62.7
1,367
1,528
1,958
2,054
2,129
Retained earnings
-316
-679
-812
-1,157
-1,614
-1,891
-2,112
Other comprehensive income
0.16
-8.22
-16.4
-15.9
-25.4
4.17
Shareholders' equity
-462
-19.4
-617
547
355
328
137
21.3
Total equity
-462
-19.4
-617
547
355
328
137
21.3
Total liabilities and equity
317
290
856
1,080
1,103
898
792
Shares outstanding
1.15
16.8
17.4
421
22.8
24.3
Cash flow statement
FY2020
FY2020
FY2022
FY2022
FY2023
FY2024
FY2025
FY2026
Net income
-134
-315
-197
-132
-345
-458
-277
-220
Depreciation and amortization
7.7
10.1
16.5
25.1
28.5
29.2
27
Stock-based compensation
2.94
4.95
67.3
93.4
117
75.7
64.7
Deferred income tax
0
0
-3.31
-3.56
-2.2
0.3
-0.44
Change in receivables
-8.7
3.29
-38.4
-94.6
36.5
17.4
12.9
Change in inventory
-1.47
-9.59
-1.99
-39.4
-174
-17
7.18
Change in payables
15.7
-0.16
-0.49
7.93
31.5
Cash from operations
-87.9
-2.12
-91.8
-157
-267
-329
-147
-62.8
Capital expenditures
-14.9
-11.5
-16.4
-18.6
-19.4
-12.1
-4.17
Acquisitions
0
0
-205
-2.76
0
0
Purchases of investments
-180
0
0
-285
0
0
Cash from investing
-61.9
0.57
35.5
-222
-126
85.6
-12.1
-4.17
Debt repaid
0
0
-36.1
0
0
0
-39.7
Stock issued
2.22
0
0
49.5
287
10.2
0
Cash from financing
17.2
1.27
129
550
373
307
28.5
-20
Exchange rate effect
0.13
0.14
-1.03
-0.73
0.09
-2.36
4
Net change in cash
-133
-0.29
72.7
170
-21.1
63.2
-133
-83
Free cash flow
-103
-103
-174
-286
-348
-159
-67
Interest paid
3.41
2.8
0.35
4.93
10.8
10.7
0.46
Income taxes paid
0.15
0.48
0.17
0.27
0.6
1.11
2.75
2.88
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to July 31, 2026; growth uses fiscal years. Valuation uses the share price of $8.93 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
32.1%
Gross profit / revenue.
Operating margin
-41.2%
Operating income / revenue.
EBITDA margin
-36.8%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
-39.4%
Pre-tax income / revenue.
Net margin
-40.6%
Net income / revenue.
FCF margin
-15.8%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
-14.9%
Cash from operations / revenue.
Return on assets (ROA)
-25.3%
Net income / average total assets.
Return on invested capital (ROIC)
-133.7%
Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue
31.7%
Research and development expense / revenue.
Stock-based pay / revenue
11.6%
Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue
0.9%
Capital expenditures / revenue.
D&A / revenue
4.4%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
-1.4%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
-4.2%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y
22.9%
Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y
24.8%
Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y
13.5%
Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y
30.7%
Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y
-84.5%
Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y
-60.9%
Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets growth, 1y
-11.8%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
-9.8%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
22.3%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y
8.0%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
11.4%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y
98.6%
Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
1.07x
Current assets / current liabilities.
Quick ratio
0.51x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.26x
(Cash + short-term investments) / current liabilities.
Debt / assets
34.1%
Total debt / total assets.
Liabilities / assets
105.2%
Total liabilities / total assets.
Net debt
$141.6M
Total debt - cash - short-term investments. Negative means more cash than debt.
Days inventory + days sales outstanding - days payables.
Per share
Metric
Value
How it is calculated
EPS, diluted
-$6.68
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$16.45
Revenue / diluted weighted shares.
FCF per share
-$2.60
Free cash flow / diluted weighted shares.
Operating cash flow per share
-$2.45
Cash from operations / diluted weighted shares.
Book value per share
-$1.34
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/S
0.53x
Market cap / revenue.
EV/Sales
0.86x
Enterprise value / revenue.
FCF yield
-29.6%
Free cash flow / market cap.
Earnings yield
-76.0%
Net income / market cap (the inverse of P/E).
What was ChargePoint Holdings, Inc.'s revenue in fiscal 2026?
ChargePoint Holdings, Inc. reported revenue of $411.2M for fiscal 2026, 1.4% lower than the year before.
Was ChargePoint Holdings, Inc. profitable in fiscal 2026?
No. It reported a net loss of $220.2M.
How much free cash flow did ChargePoint Holdings, Inc. generate in fiscal 2026?
Cash from operations of $62.8M minus capital expenditures of $4.2M left free cash flow of -$67.0M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.